Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Akebia Therapeutics (AKBA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Akebia Therapeutics 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 USA

www.akebia.com P: 617-871-2098 F: 617-871-2099

Description:

Akebia Therapeutics Inc. is a biopharmaceutical company. It focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor biology for patients with kidney disease. Akebia Therapeutics, Inc. is headquartered in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 719,038
Shares Outstanding, K 47,150
Annual Sales, $ 1,540 K
Annual Net Income, $ -135,750 K
Last Quarter Sales, $ 28,520 K
Last Quarter Net Income, $ -21,520 K
36-Month Beta 1.03
% of Insider Shareholders 7.95%
% of Institutional Shareholders 46.34%

Growth:

1-Year Total Return 93.04%
3-Year Total Return -41.28%
5-Year Total Return -42.86%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.99 on 03/06/17
Next Earnings Date 08/14/17
Earnings Per Share ttm -3.63
EPS Growth vs. Prev Qtr 53.91%
EPS Growth vs. Prev Year 44.21%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

AKBA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -3.91
Price/Earnings to Growth N/A
Return on Equity % -199.28
Return on Assets % -52.65
Profit Margin % -8,814.94
Debt/Equity 0.00
Price/Sales 465.67
Price/Cash Flow 0.00
Price/Book 12.53
Book Value/Share 1.21
Interest Coverage 0.00
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.